An Open Label, Partially Randomised, Single Dose, Crossover Study to Evaluate the PK, Oral Bioavailability and Relationship to Metabolic Parameters of Hydrocortisone and Infacort® in Healthy Adult Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 19 Apr 2017
Price : $35 *
At a glance
- Drugs Hydrocortisone (Primary) ; Hydrocortisone (Primary) ; Dexamethasone
- Indications Adrenal insufficiency; Congenital adrenal hyperplasia
- Focus Pharmacokinetics
- Sponsors Diurnal
- 31 Aug 2018 Biomarkers information updated
- 24 Jan 2014 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 15 Oct 2013 New trial record